[Arrhythmogenic effect of anti-arrhythmia agents in patients with paroxysmal supraventricular reciprocal tachycardia].
A retrospective study of the results of consecutive testing of antiarrhythmic agents was carried out in 82 patients with paroxysmal reciprocal supraventricular tachycardia. Arrhythmogenic effects of anti-arrhythmic drugs were detected in 22 (6.1%) of 359 pharmacologic tests. The electrophysiologic basis of arrhythmogenic effect is delayed impulse conduction at some point of the blood flow pathway, conducive to the emergence or maintenance of the re-entry phenomenon.
Smetnev
A S
AS
Grosu
A A
AA
Shevchenko
N M
NM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013614:Tachycardia, Paroxysmal / Q000139:chemically induced* / Q000188:drug therapy; D013617:Tachycardia, Supraventricular / Q000139:chemically induced* / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents
Aritmogennoe deĭstvie antiaritmicheskikh preparatov u bol'nykh s paroksizmal'noĭ nadzheludochkovoĭ retsiproknoĭ takhikardieĭ.